by Julie Manz | Aug 18, 2025 | The Doctor's Dose
The Manz Trader Readiness Inventory: Measuring Psychological Fitness for Day Trading Success in day trading is about much more than mastering technical setups or memorizing chart patterns. While strategy and execution are essential, they’re only part of the equation....
by ADRIAN MANZ | Aug 18, 2025 | The Doctor's Dose
Intel Government Stake Talks and Day Trading Implications The Trump administration is reportedly considering a 10% equity stake in Intel (INTC), which would convert billions in CHIPS Act funding into ownership. The proposal underscores Washington’s deepening...
by ADRIAN MANZ | Aug 18, 2025 | The Doctor's Dose
Retail Earnings, Tariffs, and Day Trading: Where the Real Risk Lies Why this week matters Headline numbers may look fine; the risk is guidance as retailers speak to the back half (B2S and holiday). Tariff pass-through is the swing factor: modest so far, but price...
by ADRIAN MANZ | Aug 18, 2025 | The Doctor's Dose
Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...
by ADRIAN MANZ | Aug 18, 2025 | The Doctor's Dose
DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...
by ADRIAN MANZ | Aug 17, 2025 | The Doctor's Dose
Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...
by admin | Aug 16, 2025 | The Doctor's Dose
Zelensky–Trump Meeting Market Impact: What Traders Should Expect As President Volodymyr Zelensky returns to Washington with a cohort of European leaders, the Zelensky–Trump meeting market impact will hinge on three things: the shape of potential security guarantees,...
by ADRIAN MANZ | Aug 15, 2025 | The Doctor's Dose
Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...
by ADRIAN MANZ | Aug 14, 2025 | The Doctor's Dose
Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...
by ADRIAN MANZ | Aug 13, 2025 | The Doctor's Dose
Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...
